Analyzing 13C Tracing Data

Five steps, three of them merely descriptive.

The Five Steps

StepWhat happensDecision that matters
1. Peak extractionFragment or parent masses converted to intensitiesWhich adduct and fragment to use
2. Natural abundance correctionRemove the ¹³C contributed by unlabelled atomsWhich correction algorithm
3. Mass isotopomer distributionFraction of each mass in each metaboliteWhether to include the lowest mass
4. Model definitionNetwork, compartments, exchange reactionsHow much compartmentation to include
5. FittingOptimise fluxes to match the MIDsWhether the data constrain the parameters

Important distinction. Steps 1–3 produce a description of labelling. Steps 4–5 produce a flux estimate. Many "flux analysis" papers stop at step 3, and the resulting numbers are labelled fractions with flux units attached.

Part 1 — Natural Abundance and Its Traps

IssueDetail
Carbon natural abundance~1.1% ¹³C, which produces a non-zero baseline in every mass channel
Correction algorithmDifferent algorithms give slightly different results at high label fractions
Low-enrichment samplesSmall differences are dominated by the correction
Over-correctionApplying a correction to data already background-subtracted
Fragment-specific abundanceSome fragments include atoms with different abundance contributions

Readout note. The lowest mass isotopologue (m+0) is often discarded because it is dominated by unlabelled material. That is acceptable for relative comparisons, but it removes information needed for mass balance, and an MFA fit that omits m+0 estimates fewer parameters than the network requires.

Part 2 — Steady State and Time

AssumptionHow to checkWhat happens if violated
Isotopic steady stateMIDs stable across two timepointsFluxes describe a transient
Metabolic steady statePools and extracellular rates stableThe model has no unique solution
No recyclingLabel does not return via a different routeOverestimated flux in the labelled route
Complete mixing of the tracerPrecursor enrichment knownFluxes scaled incorrectly

Important distinction. Isotopic steady state is not metabolic steady state. A cell can reach stable labelling while its pool sizes are changing, and it can have stable pools while labelling is still evolving. Both need checking, and they are checked differently.

Part 3 — Model Definition

DecisionOptionsConsequence
CompartmentationSingle pool versus cytosolic/mitochondrialSingle-pool models misassign mitochondrial fluxes
Exchange reactionsInclude or omitOmitting them forces net flux to equal label flux
Biomass drainInclude a growth term or notOtherwise carbon accumulates in the model
Reversible stepsSpecify reversibilityReversibility changes label distribution substantially
Tracer mixtureOne tracer versus severalMultiple tracers improve identifiability

Caveat on identifiability. A model with more fluxes than the data can constrain produces a fit with wide or undefined confidence intervals. That is not a numerical problem to be worked around; it is a statement that the experiment cannot answer the question. Reporting a single best-fit value without intervals hides it.

Part 4 — Software and Practicalities

ToolStrengthsNote
INCAWidely used; MFA with isotopomersRequires a defined network
OpenFLUX / 13CFLUX2Open source; flexibleSteeper learning curve
Custom scriptsFull controlReproducibility burden
Mid-correction tools (e.g. IsoCorrectoR)Handles natural abundance for metabolomicsNot an MFA tool

Readout note. Whatever the tool, the analysis should report: the tracer, the enrichment, the timepoints, the MID data, the network as supplied, the fit residuals, and confidence intervals. Without these, the result cannot be reproduced or evaluated.

Part 5 — Common Failures

  • • Labelled fractions reported as fluxes.
  • • Natural abundance not corrected, or corrected twice.
  • • Single timepoint used as if it were steady state.
  • • Single-pool model applied to a compartmented pathway.
  • • Exchange reactions omitted, so reversibility is invisible.
  • • No confidence intervals.
  • • Precursor enrichment assumed rather than measured.
  • • Network not reported, so the model cannot be checked.
  • • Fits reported without residuals.

Part 6 — Where This Article Connects

This is the workflow article for the mitochondrial cluster: the tracing-principles article covers tracer choice, and this one covers what happens to the data afterwards. The citrate and succinate patterns discussed in the pillar are the inputs, and the oncometabolite article uses the same workflow for 2-HG.

If you need tracing analysed with a reported network and confidence intervals, we can scope the analysis with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Correction algorithms, model structure and identifiability depend on the tracer, the analytical platform and the network supplied; results are specific to that combination.

A mass isotopomer distribution is a description of labelling; a flux estimate requires a model, extracellular rates and an assessment of identifiability.

Scientific interpretation and experimental design

  • • Five steps, three of them descriptive.
  • • Correct for natural abundance once.
  • • Check steady state twice. Isotopic and metabolic.
  • • Compartmentation changes the answer.
  • • Report the network.
  • • No intervals, no flux claim.

Selected references for further reading

  • • Antoniewicz MR. A guide to ¹³C metabolic flux analysis for the cancer biologist. Experimental & Molecular Medicine. 2018;50:1–13.
  • • Young JD. INCA: a computational platform for isotopically non-stationary metabolic flux analysis. Bioinformatics. 2014;30:1333–1335.
  • • Wiechert W, et al. OpenFLUX: efficient modelling software for ¹³C-based metabolic flux analysis. Microbial Cell Factories. 2009;8:25.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: